PSMB6: A Promising Drug Target and Biomarker for Proteasome Delta Chain-mediated Signaling

Target Name: PSMB6

NCBI ID: G5694

PSMB6

PSMB6: A Promising Drug Target and Biomarker for Proteasome Delta Chain-mediated Signaling

Proteasome delta chain (PSMB6) is a key protein that plays a crucial role in cell signaling pathways, including cell growth, apoptosis, and inflammation. The PSMB6 gene has been well-studied, and its functions have been extensively characterized. One of the most significant findings is its involvement in the regulation of cell apoptosis. PSMB6 has been shown to be a potent inhibitor of cell apoptosis, and its overexpression has been shown to promote cell survival.

PSMB6 functions as a negative regulator of the B-cell terminal differentiation antigen (BET) gene. BET is a transmembrane protein that plays a crucial role in cell signaling pathways, including cell survival, angiogenesis, and inflammation. The B-cell terminal differentiation antigen (BET) gene is a key regulator of B-cell terminal differentiation and has been implicated in various diseases, including cancer.

PSMB6 functions as a positive regulator of the p53 gene. The p53 gene is a well-known tumor suppressor gene that plays a crucial role in the regulation of cell apoptosis. PSMB6 has been shown to physically interact with the p53 gene and promote its expression. This interaction between PSMB6 and p53 suggests that PSMB6 may be a potential drug target for the treatment of p53-related diseases.

PSMB6 has also been shown to play a role in the regulation of inflammation. inflammation is a crucial aspect of immune response and has been implicated in various diseases, including cancer. PSMB6 has been shown to regulate the expression of several pro-inflammatory genes, including NF-kappa-B, COX, and IL-1尾.

PSMB6 has also been shown to play a role in the regulation of cell signaling pathways, including the regulation of cell growth, angiogenesis, and cell-cell adhesion. PSMB6 has been shown to physically interact with several cell signaling proteins, including TGF-β, FGF, and PDGF.

PSMB6 has also been shown to play a role in the regulation of cell Cycle. PSMB6 has been shown to regulate the expression of several cell cycle genes, including CDK4, CDK6, and p21. This interaction between PSMB6 and cell cycle genes suggests that PSMB6 may be a potential drug target for the treatment of cancer.

PSMB6 has been shown to play a role in the regulation of cell migration. PSMB6 has been shown to regulate the migration of several cell types, including cancer cells. This interaction between PSMB6 and cell migration suggests that PSMB6 may be a potential drug target for the treatment of cancer.

PSMB6 has also been shown to play a role in the regulation of cell adhesion. PSMB6 has been shown to regulate the adhesion of several cell types, including cancer cells. This interaction between PSMB6 and cell adhesion suggests that PSMB6 may be a potential drug target for the treatment of cancer.

Conclusion

In conclusion, PSMB6 is a protein that has been well-studied for its functions in cell signaling pathways, including cell growth, apoptosis, and inflammation. PSMB6 has been shown to be a potent inhibitor of cell apoptosis and a positive regulator of the p53 gene. PSMB6 has also been shown to play a role in the regulation of cell signaling pathways, cell cycle, cell migration, and cell adhesion. These functions make PSMB6 a promising drug target for the treatment of various diseases, including cancer. Further research is needed to fully understand the functions of PSMB6 and its potential as a drug target.

Protein Name: Proteasome 20S Subunit Beta 6

Functions: Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex). Within the 20S core complex, PSMB6 displays a peptidylglutamyl-hydrolizing activity also termed postacidic or caspase-like activity, meaning that the peptides bond hydrolysis occurs directly after acidic residues

The "PSMB6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PSMB6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets